evidence: Second COVID-19 vaccine approved for Switzerland Bern, 12.01.2021 - On 12 January 2021 Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, approved the second COVID-19 vaccination for the Swiss market. The vaccine from Moderna, of which the federal government has ordered around 7.5 million doses, is suitable for adults from age 18. In the next few days an initial delivery of 200,000 doses will be made to the Armed Forces Pharmacy, which will distribute the vaccine to the cantons. Together with the Pfizer/BioNTech vaccine approved by Swissmedic on 19 December 2020, around half a million doses of vaccine are available in Switzerland in January. The first priority will be to vaccinate especially vulnerable people. The COVID-19 vaccine from Moderna is the second to be approved by Swissmedic. On the basis of the safety, efficacy and quality data the vaccine is suitable without age restrictions for all adults aged 18 and over. The federal government has ordered 7.5 million doses from Moderna.